Navigation Links
China-Biotics, Inc. to Attend the SIG 3rd Annual Beijing Management Summit

SHANGHAI, Sep. 4 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced that the Company's management team will attend the Susquehanna International Group of Companies ("SIG") 3rd Annual Beijing Management Summit.

The SIG 3rd Annual Beijing Management Summit a two-day conference that brings together executives from public and private companies based in China and other emerging Asian economies. The event will showcase leading companies in the Chinese Consumer, Health Care, Internet, and Technology sectors, as well as companies in the IT Services/Outsourcing and Financial Technologies sectors. The event format will consist of one-on-one meetings and company presentations.

The date and location of China-Biotics' one-to-one meetings at the SIG 3rd Annual Beijing Management Summit are as follows:

    Date:         September 16 and September 17, 2009
    Management:   Mr. Lewis Fan, Chief Financial Officer
    Venue:        The Grand Hyatt Beijing Hotel
                  1 East Chang An Avenue
                  Beijing 100738

During the conference, the management will be available to meet with analysts and portfolio managers. Interested parties and investors who wish to meet with China-Biotics management may contact or call (310) 926-8038. Participation in the SIG 3rd Annual Beijing Management Summit is by invitation only.

About China-Biotics, Inc.

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company has operations in Shanghai. Its proprietary product portfolio contains live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang. China-Biotics plans to launch 300 Shining brand retail outlets in major cities in China. Currently, China-Biotics is strategically expanding its production capacity of probiotics to meet growing demand in the bulk additive market. For more information, please visit .

    For more information, please contact:

     Lewis Fan, CFO
     China-Biotics, Inc.

    CCG Investor Relations
     Crocker Coulson, President
     Phone: +1-646-213-1915 (New York)

SOURCE China-Biotics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Reports First Quarter Fiscal 2010 Financial Results
2. China-Biotics, Inc. Receives High-Technology Enterprise Certification to Qualify for Preferential Income Tax Rate
3. China-Biotics, Inc. Applies for Four Patents on Probiotic Formulations
4. China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2009 Financial Results
5. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2009 Financial Results
6. China-Biotics, Inc. to Join Russell 3000 Index
7. China-Biotics, Inc. to Attend Digestive Disease Week 2009
8. China-Biotics, Inc. to Present at CCG Investor Relations China Rising Conference
9. China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed
10. China-Biotics, Inc. Appoints New Chief Financial Officer
11. China-Biotics, Inc. to Present at Roth Capital Partners 21st Annual OC Growth Stock Conference
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/25/2015)... , Nov. 25, 2015  PharmAthene, Inc. (NYSE MKT: ... adopted a stockholder rights plan (Rights Plan) in an ... loss carryforwards (NOLs) under Section 382 of the Internal ... --> PharmAthene,s use of its NOLs could be ... as defined in Section 382 of the Code. In ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... 2015 The Global Genomics ... professional and in-depth study on the current state ... ) , The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):